Zongertinib shows major impact on HER2 lung cancer
Independent - 17-Oct-2025Targeted pill shows strong tumour reduction and better quality of life for HER2-mutant patients
Join the club for FREE to access the whole archive and other member benefits.
Hospital dedicated to cancer diagnosis, treatment, research and education
The Royal Marsden is a world-leading cancer centre specialising in cancer diagnosis, treatment, research and education.
We have two hospitals: one in Chelsea, London, and another in Sutton, Surrey. Also in Surrey, we have a Medical Daycare Unit in Kingston.
We are also partners with The Institute of Cancer Research. Through this partnership, we undertake groundbreaking research into new cancer drug therapies and treatments. The partnership makes us the biggest and most comprehensive cancer centre in Europe, with a combined staff of 3,500.
Visit website: https://www.royalmarsden.nhs.uk/
the-royal-marsden-nhs-foundation-trust
See alsoDetails last updated 27-Oct-2019
Targeted pill shows strong tumour reduction and better quality of life for HER2-mutant patients
A groundbreaking procedure at The Royal Marsden restores tissue using precision robotics
This could lead to more personalised treatment plans and better outcomes
Weakened form of herpes virus showed promising results for various advanced cancers
Precisely targeted therapy shrank tumours and extends life by 38% in men
Consultant Medical Oncologist and Director of Clinical Research at The Royal Marsden in London and Surrey.